OpGen (NASDAQ:OPGN) Shares Pass Below 50 Day Moving Average of $4.12

OpGen, Inc. (NASDAQ:OPGN)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.12 and traded as low as $2.35. OpGen shares last traded at $2.36, with a volume of 11,959 shares trading hands.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of OpGen in a report on Saturday, May 25th. They issued a “sell” rating on the stock.

OpGen Stock Performance

The stock’s fifty day simple moving average is $4.12 and its 200-day simple moving average is $4.43. The company has a market capitalization of $3.16 million, a PE ratio of -0.04 and a beta of -0.65.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in OpGen stock. Chase Investment Counsel Corp acquired a new stake in shares of OpGen, Inc. (NASDAQ:OPGN) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 331,890 shares of the medical research company’s stock, valued at approximately $230,000. Chase Investment Counsel Corp owned about 2.63% of OpGen at the end of the most recent reporting period. 2.68% of the stock is currently owned by institutional investors.

OpGen Company Profile

OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.